Encompass Health (NYSE:EHC) Issues Quarterly Earnings Results

Encompass Health (NYSE:EHC) announced its quarterly earnings results on Thursday. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12, Zacks reports. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Encompass Health updated its FY 2025 guidance to 4.670-4.960 EPS.

Encompass Health Stock Up 1.3 %

EHC stock opened at $99.86 on Friday. The stock has a market capitalization of $10.06 billion, a P/E ratio of 22.39, a P/E/G ratio of 1.18 and a beta of 0.90. Encompass Health has a 52 week low of $72.37 and a 52 week high of $104.55. The firm has a 50-day simple moving average of $96.28 and a 200-day simple moving average of $95.19. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88.

Analyst Upgrades and Downgrades

Several analysts recently commented on the company. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a report on Friday. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Friday. Truist Financial reissued a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada lifted their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, KeyCorp increased their target price on shares of Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. One analyst has rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $107.33.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.